Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada.
about
Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time.Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
P2860
Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Risperidone long-acting inject ...... outpatient setting in Canada.
@ast
Risperidone long-acting inject ...... outpatient setting in Canada.
@en
Risperidone long-acting inject ...... outpatient setting in Canada.
@nl
type
label
Risperidone long-acting inject ...... outpatient setting in Canada.
@ast
Risperidone long-acting inject ...... outpatient setting in Canada.
@en
Risperidone long-acting inject ...... outpatient setting in Canada.
@nl
prefLabel
Risperidone long-acting inject ...... outpatient setting in Canada.
@ast
Risperidone long-acting inject ...... outpatient setting in Canada.
@en
Risperidone long-acting inject ...... outpatient setting in Canada.
@nl
P2093
P2860
P356
P1433
P1476
Risperidone long-acting inject ...... outpatient setting in Canada.
@en
P2093
Laura Lammers
Richard Williams
P2860
P2888
P356
10.1186/1471-244X-13-155
P577
2013-05-30T00:00:00Z
P6179
1041803488